IDSA releases updated guidance for treating drug-resistant gram-negative infections

The Infectious Diseases Society of America (IDSA) has issued revised guidance for managing antimicrobial-resistant gram-negative infections in the U.S. This update, building on previous 2024 recommendations, outlines preferred and alternative treatment strategies, including transitions to oral therapy and appropriate durations. This is important for clinicians to ensure effective patient care amidst rising antibiotic resistance.